Introduction: Global partnerships and collaboration of pharmacy schools between the United States and Asian countries have great impacts on the development of clinical pharmacy. This article describes the decadal experience of Taipei Medical University (TMU) concerning clinical pharmacy development via partnerships with the American College of Clinical Pharmacy (ACCP) and a number of schools of pharmacy and hospital pharmacies in the U.S. and Asian countries. We specifically focus on describing the process and outcomes of the specialist pharmacist (SP) system and the residency program. Methods: After the 6-year Doctor of Pharmacy (Pharm.D.) program at TMU was approved in 2013, a number of strategies were used to advance clinical pharmacy development, including experiential faculty and site preparation, didactic faculty development, and international conferences. For the purpose of this paper, documents from TMU-affiliated hospitals (Taipei Medical University Hospital [TMUH], Wan Fang Hospital [WFH], and Shuang Ho Hospital [SHH]) and the TMU College of Pharmacy regarding the SP system and the residency program were reviewed and analyzed. Results: In 2017, TMU passed the SP career ladder system and WFH started the pharmacy residency program. As of 2020, there are a total of 7 SPs certified in three major TMU-affiliated hospitals. Two pharmacy residents completed training in WFH. Global engagement with universities in Vietnam and Indonesia allowed TMU to give back to the global community by offering faculty development and clinical pharmacy preceptor training. Conclusion: Through global partnerships, innovations in clinical pharmacy development can be diffused more widely and have resulted in practice changes such as an SP system and residency program at TMU. The experiences may provide value for those seeking to expand clinical pharmacy development via international engagement.
|頁（從 - 到）||897-904|
|期刊||JACCP Journal of the American College of Clinical Pharmacy|
|出版狀態||已發佈 - 8月 1 2020|
ASJC Scopus subject areas